Drug intelligence / Profile preview

acetylshikonin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Acetylshikonin is a naturally occurring **acetate ester** and a **hydroxy-1,4-naphthoquinone** derivative found in plants such as Lithospermum erythrorhizon and Arnebia species[2][5][8]. It is characterized as a **small molecule** with prominent **anti-cancer** and **anti-inflammatory** properties. Mechanistically, acetylshikonin acts as a **microtubule-targeting agent (MTA)** by inhibiting tubulin polymerization, causing G2/M phase cell cycle arrest and promoting apoptosis in various cancer cell lines (including hepatocellular carcinoma, renal cell carcinoma, and others)[3][6]. It also inhibits cytochrome P450 2J2 (CYP2J2) activity and induces nuclear translocation of forkhead box protein O3 (FOXO3)[6]. These properties collectively position acetylshikonin as a promising preclinical lead for research in oncology[3][6].

Other names
Shikonin, acetylShikonin acetateO-Acetylshikonin(R)-acetyl shikoninRacemic Acetyl Shikonin Labeled d7
02

Targets

TUBB (Tubulin (alpha and beta subunits))FOXO3 (Forkhead box protein O3)CYP2J2 (Cytochrome P450 family 2 subfamily J member 2)

Beyond the preview

Go deeper on acetylshikonin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylshikonin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call